Voriconazole Tablets Recalled Due to Manufacturing Practice Deviations
Amerisource Health Services is recalling Voriconazole 50 mg tablets distributed nationwide due to current Good Manufacturing Practice deviations related to repackaging.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall initiated due to manufacturing process deviations in repackaging. The source describes a precautionary quality control recall with no mention of reported illnesses or injuries. Per the rubric, precautionary recalls without documented patient harm are classified as Moderate.
Plain-English summary
Amerisource Health Services LLC is recalling Voriconazole tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses. The product was distributed nationwide in the United States. The recall involves Lot #1014138 with expiration date 04/30/2025, with carton NDC 60687-294-21 and unit dose NDC 60687-294-11.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. The supplier repackaged the product, which triggered the need for this recall.
This recall affects all patients, healthcare providers, hospitals, and pharmacies that may have received the affected lot of this prescription antifungal medication.
The recalled product
- Product
- VORICONAZOLE (VORICONAZOLE)
- Brand
- VORICONAZOLE
- Manufacturer
- Amerisource Health Services LLC
- Category
- Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 1014138
- Exp 04/30/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VORICONAZOLE
- ModerateGlenmark Voriconazole Tablets Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-04-16
- ModeratePrescription Voriconazole Antifungal Tablets Recalled Nationwide for Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- HighVoriconazole Oral Suspension Recalled for Missing Package Insert
FDA (Drugs) · 2024-02-28
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27